|
|
Home  CMSC Online For MS Professionals Presentations
|
Webcast - Become Study |
|
|
CMSC MS Research Update
A Webcast for Healthcare Professionals
THE BECOME STUDY
Description:
BECOME is the first head-to-head randomized prospective study comparing Betaseron and Copaxone by magnetic resonance imaging (MRI) parameters in relapsing multiple sclerosis (MS).
Presentor:
Diego Cadavid, MD, Principal Investigator
Associate Professor
Dept. of Neurology and Neuroscience
UMDNJ- New Jersey Medical School
Dr. Cadavid has disclosed that he has received grants and/or research support from Bayer HealthCare Pharmaceuticals.
Release Date: June 14, 2007
Expiration Date: June 14, 2008
Estimate time to complete activity: 1 hour
Objectives: Upon completion of this webcast, participants will be able to: - Discuss the primary outcome of the study
- Describe the emerging patterns of MRI activity in both treatment groups
- Cite professional practice implications based on study outcomes
Target Audience:
This presentation is intended for physicians, nurses, nurse practitioners and other healthcare professionals providing care to patients with multiple sclerosis.
Accreditation:
For Physicians:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for continuing Medical Education through the joint sponsorship of Medical Education Collaborative, Inc. (MEC) and Nurse Practitioner Alternatives, Inc. MEC is accredited by the ACCME to provide continuing medical education for physicians.
Medical Education Collaborative designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The employees of Medical Education Collaborative have no financial relationships to disclose.
For Nurses:
This Educational Design Activity is cosponsored by the Consortium of Multiple Sclerosis Centers and Nurse Practitioner Alternatives, Inc., approved as a provider of continuing nursing education by the Maryland Nurses Association, an accredited approver of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. Awarded 1.0 contact hour(s) of continuing nursing education for RNs and APNs; none of these credits is in the area of pharmacology.
Approval Code: IOMSN061407
View the presentation (please use presentation number v22781)
Material presented during this research update is sponsored by the Consortium of Multiple Sclerosis Centers. This webcast was supported by an unrestricted educational grant from Bayer HealthCare Pharmaceuticals.
|
|
